News & Updates
Filter by Specialty:
Functional abdominal pain in IBD kids in remission worsens fatigue, HR-QoL
Functional abdominal pain among inflammatory bowel disease children in remission (IBP-FAPD) is common and leads to worse fatigue and lower health-related quality of life (HR-QoL), a recent study has found. Past disease severity does not significantly predict IBP-FAPD.
Functional abdominal pain in IBD kids in remission worsens fatigue, HR-QoL
06 Oct 2021
Vedolizumab yields sustained improvements in fistulizing Crohn’s disease
Intravenous dosing regimens of vedolizumab appear to favourably alter outcomes in patients with fistulizing Crohn’s disease, according to data from the phase IV ENTERPRISE trial.
Vedolizumab yields sustained improvements in fistulizing Crohn’s disease
05 Oct 2021
Azathioprine shows promise in maintenance treatment of autoimmune pancreatitis
Treatment with azathioprine helps prevent relapse of autoimmune pancreatitis, according to the results of a systematic review and meta-analysis.
Azathioprine shows promise in maintenance treatment of autoimmune pancreatitis
04 Oct 2021
Osteopathy prevalent among patients with chronic pancreatitis
Majority of patients with chronic pancreatitis also have osteoporosis or osteopenia, with risk factors including older age and lower body mass index, among others, according to a study.
Osteopathy prevalent among patients with chronic pancreatitis
30 Sep 2021
Olanzapine a favourable alternative to dexamethasone for CINV
Olanzapine administered at a dose of 5 mg was noninferior to dexamethasone and is associated with fewer adverse effects than dexamethasone for chemotherapy-induced nausea and vomiting (CINV), according to data presented at ESMO 2021.
